Fig. 3
From: Identification and evaluation of Pharmacological enhancers of the factor VII p.Q160R variant
Dose-response analysis of abexinostat and tyloxapol on FVII activity in cell culture medium from CHO-K1 cells transiently expressing rFVII-160R. The cells were treated with indicated concentrations of abexinostat (A) or tyloxapol (B) for 1.5 h before FVII activity was measured. EC50 value is indicated (dotted line).
